Second neoplasms in chronic lymphocytic leukemia: Are case-group studies useful?
Molica
Stefano
S
Department of Hematology-Oncology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy. molica@libero.it
D000970:Antineoplastic Agents / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000188:drug therapy* / Q000473:pathology*; D016609:Neoplasms, Second Primary / Q000150:complications / Q000188:drug therapy* / Q000473:pathology*
D000970:Antineoplastic Agents